HuagongsheHuagongshe Chemistry Print Report · For research reference only
2-(Piperidin-4-yl)quinoxaline → 2-(1-{4-[6-(4-Fluorophenyl)-imidazo[1,2-a]pyrimidin-7-yl]-benzyl}-piperidine-4-yl)-quinoxaline
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2-(Piperidin-4-yl)quinoxaline | HCID 21198026 | — |
| Reactant | 4-[6-(4-Fluorophenyl)imidazo[1,2-a]pyrimidin-7-yl]-benzaldehyde | HCID 86703020 | — |
| Product | 2-(1-{4-[6-(4-Fluorophenyl)-imidazo[1,2-a]pyrimidin-7-yl]-benzyl}-piperidine-4-yl)-quinoxaline | HCID 68753206 | — |
Reaction Steps
The compound is prepared in analogy to example 33.0. 216 mg (0.756 mmol) 2-Piperidine-4-ylquinoxaline are reacted with 200 mg (0.63 mmol) 4-[6-(4-fluorophenyl)-imidazo[1,2-a]pyrimidin-7-yl]-benzaldehyde. After the usual work-up and purification 201 mg (58.9%) of the title compound are obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08957064B2 |
| Source dataset | uspto-grants-2015_02 |
| ORD ID | ord-10b308f7e25c4ee7b87c81629f48adc5 |
| Source note | uspto-grants-2015_02 |